041830

InBody is a medical device manufacturer specializing in body composition analysis technology. Founded in 1996, the company develops and produces professional and home-use body composition analyzers, automatic blood pressure monitors, height meters, and related software. Its product portfolio includes the InBodyDial H30, InBodyDial H40, and InBodyFit for the consumer market, alongside professional-grade devices used in clinical and sports settings. InBody operates through a global network of subsidiaries and distributors, with key markets in the United States, Japan, China, and Europe. The company serves customers including hospitals, fitness centers, obesity clinics, military units, schools, and individual consumers. It maintains production facilities in South Korea and China, and holds regulatory certifications from the US FDA, European CE, and Japanese JPAL. InBody also leverages its data assets to develop AI-driven healthcare solutions and software services.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Medical Devices Homepage inbody.com
Sector Healthcare IR page —
Tags
body composition analysis, bioelectrical impedance analysis, blood pressure monitoring, home healthcare, sports medicine, obesity management, preventive medicine, digital health, ai healthcare, InBody, InBodyDial H30, InBodyDial H40, InBodyFit, BWA, Biospace China Co. Ltd., InBody China Medical Technology Co. Ltd., Inbody Europe B.V., InBody UK LIMITED, InBody Asia, InBody India, InBody Oceania, InBody Asia Pte.
Press page —

Metrics

Valuation  
Market cap —
Market cap (USD) —
P/E —
PEG —
P/BV —
P/S —
P/OCF —
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 10.4%
ROI 9.6%
ROIC 9.0%
Profit margin 13.1%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) -3.2%
Quality  
Profitable Yes
Margin expanding No
Buying back stock —
Diluting (TTM) —
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) —
Quality score 54.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 233.948B 204.465B 170.351B 160.004B 137.837B 107.122B 117.059B 99.635B 93.254B 79.848B 68.949B 48.94B 36.787B
Net profit 30.633B 33.143B 36.723B 33.816B 34.033B 17.518B 20.428B 19.671B 19.322B 16.987B 17.311B 8.879B 6.194B
Free cash flow 28.865B 22.315B 31.235B 25.039B 19.059B 26.814B 21.134B -23.159B 13.264B 10.607B — 8.792B —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (KRW) 11B 12.3B 12B 10.6B 8.76B 17.3B 18.1B 17.4B 25.2B 31.6B
↳ YoY growth +10.0% +12.0% -2.2% -12.1% -17.0% +97.9% +4.4% -3.7% +44.5% +25.5%
↳ 5y CAGR +24.0% +20.4% -2.5% +9.6% +8.1% +7.7% +19.0% +29.3%
Borrowings, current (KRW) — — — — — — — 0.00 0.00 559M
Lease liabilities (KRW) — — — 4.81B 4.79B 3.87B 6.4B 6.08B 8.42B 9.78B
Cash and deposits (KRW) 10.3B 11.2B 9.63B 14.4B 17B 18.6B 21.6B 22.3B 31B 52.4B
Intangible assets (KRW) 1.69B 1.51B 1.14B 758M 727M 1.32B 1.68B 1.22B 2.03B 1.85B
Right-of-use assets (KRW) — 0.00 0.00 4.63B 4.7B 3.77B 6.31B 5.91B 7.94B 9.75B
Net debt (borrowings + leases - cash) (KRW) — — — — — — — -16.2B -22.6B -42B
Cash flow detail
Operating cash flow (KRW) 18.2B 18.6B 17.7B 24.2B 28.5B 30.4B 30.4B 38.7B 28.6B 35.8B
Purchases of property, plant and equipment (KRW) -7.63B -5.31B -40.9B -3.07B -1.69B -11.3B -5.38B -7.45B -6.26B -6.91B
Purchases of intangible assets (KRW) -774M -269M -74.8M -198M -233M -545M -637M -192M -1.29B -509M
Dividends paid (cash effect) (KRW) -1.09B -1.36B -1.62B -1.62B -1.86B -1.82B -2.61B -3.91B -4.56B -5.04B
Share buybacks (cash effect) (KRW) — -2.85B -258M -3.74B -5B — — 0.00 -7.47B -12.5B
Interest paid (cash effect) (KRW) — — -122M -3.15M -126M -104M -122M -334M -388M -497M
Income taxes paid (cash effect) (KRW) -5.18B -3.79B -4.02B -8.39B -5.58B -4.61B -8.07B -11.9B -10B -10.1B
Free cash flow (OCF - PPE - intangibles) (KRW) 9.83B 13B -23.2B 20.9B 26.6B 18.5B 24.4B 31B 21B 28.4B
Income detail
Total comprehensive income (KRW) 17.1B 18.4B 19.7B 20.7B 17.2B 35.5B 34.1B 37.2B 35.8B 30.6B
Comprehensive income to owners (KRW) 17.1B 18.4B 19.8B 20.7B 17.2B 35.5B 34.1B 37.4B 36.2B 31.3B
Reported Apr 2, 2018 Mar 30, 2020 Mar 30, 2020 Aug 26, 2020 Mar 16, 2021 Mar 18, 2024 Mar 18, 2024 Mar 18, 2026 Mar 18, 2026 Mar 18, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

주식등의대량보유상황보고서(약식) Bull 0 Bear 0 Routine
주식등의대량보유상황보고서(약식) Bull 0 Bear 0 Routine

Prompts

InBody (ticker 041830), listed in South Korea.

ETFs Holding InBody

ETF Weight in ETF Shares Market value As of
DEXC 0.02% 1,559 $ 46.461K Nov 12, 2026
DFSE 0.01% 1,657 $ 49.382K Nov 12, 2026
DFEV 0.01% 4,160 $ 123.976K Nov 12, 2026
DFEM 0.00% 13,927 $ 415.052K Nov 12, 2026
DFAE 0.00% 9,349 $ 278.618K Nov 12, 2026
DFAX 0.00% 7,788 $ 232.098K Nov 12, 2026